Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit) [NA]
A UCSF-sponsored clinical trial called 'Tools To Be Fit' aims to improve nutrition and physical activity among cancer survivors and is curre…
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: Ablative Radioembolization of Renal Cell Carcinoma Trial [Phase 2]
A Phase 2 clinical trial evaluating ablative radioembolization for renal cell carcinoma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-18Clinical Trial Update: Imaging of Solid Tumors Using 18F-TRX [Phase 1]
A Phase 1 study is evaluating imaging of solid tumors with the radiotracer 18F-TRX. The trial is currently recruiting and includes prostate …
-
CLINICAL_TRIALS trial_result · 2025-07-18Clinical Trial Update: NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours [Phase 1, Phase 2]
NuCana plc announced termination of a Phase 1/2 trial evaluating NUC-3373 in combination with other agents for patients with advanced solid …
-
CLINICAL_TRIALS research · 2025-07-15Clinical Trial Update: A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products
This clinical trial update reports long-term follow-up of participants treated with A2 Biotherapeutics' gene therapy products in solid tumor…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-07-11Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Nivolumab With Ipilimumab in Participants With Untreated Advanced Kidney Cancer Conducted in India [Phase 4]
Phase 4 study evaluating the safety and efficacy of nivolumab plus ipilimumab in untreated advanced renal cell carcinoma completed in India,…
-
CLINICAL_TRIALS trial_result · 2025-07-11Clinical Trial Update: Real-Life Effectiveness and Safety in Participants With Advanced/Metastatic Renal Cell Carcinoma Starting 1st Line Nivolumab and Ipilimumab Combination Therapy or Nivolumab Monotherapy After Prior Therapy
Real-world study assessing effectiveness and safety of first-line nivolumab plus ipilimumab versus nivolumab monotherapy (after prior therap…
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: A Study Based on CT Radiomics for Distinguishing Benign From Malignant Renal Tumors and Assessing Their Aggressiveness.
A clinical trial update describes a study using CT radiomics to distinguish benign from malignant renal tumors and assess their aggressivene…
-
CLINICAL_TRIALS trial_result · 2025-07-10Clinical Trial Update: Study of Front Line Therapy With Nivolumab and Salvage Nivolumab + Ipilimumab in Patients With Advanced Renal Cell Carcinoma [Phase 2]
Phase 2 study evaluating front-line nivolumab therapy with salvage nivolumab plus ipilimumab in patients with advanced renal cell carcinoma …
-
CLINICAL_TRIALS trial_result · 2025-07-10Clinical Trial Update: A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001) [Phase 1]
Phase 1 trial update of belzutifan (PT2977, MK-6482) in patients with advanced solid tumors; study status is Phase 1 and not recruiting.
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: Vorolanib Monotherapy or in Combination With Toripalimab as Adjuvant Therapy for Patients With Intermediate-high Risk of Recurrence in Renal Cell Carcinoma [Phase 2]
A Phase 2 trial is evaluating vorolanib as monotherapy or in combination with toripalimab as adjuvant therapy for intermediate-high risk ren…
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study using CRISPR-edited HLA donor kidneys to reduce transplant rejection risk, with recru…
-
CLINICAL_TRIALS trial_result · 2025-07-04Clinical Trial Update: A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors [Phase 1]
This Phase 1 trial assesses Autogene Cevumeran (RO7198457) as a single agent and in combination with atezolizumab across multiple locally ad…
-
CLINICAL_TRIALS research · 2025-07-03Clinical Trial Update: Primary Tumor Ablation and Outcome in Metastatic Renal Cell Carcinoma Treated With Immunotherapy Combinations. [Phase 4]
A Phase 4 clinical trial assessing primary tumor ablation outcomes in metastatic renal cell carcinoma treated with immunotherapy combination…
-
CLINICAL_TRIALS research · 2025-07-02Clinical Trial Update: Clinical Evaluation of an Augmented Reality Intraprocedural Needle Guidance Platform for Soft Tissue Biopsy [NA]
An ongoing clinical trial evaluates an augmented reality intraprocedural needle guidance platform for soft tissue biopsy, with enrollment by…
-
CLINICAL_TRIALS research · 2025-07-02Clinical Trial Update: Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the safety and efficacy of infusions of iNKT cells and CD8+ T cells in patients with advanced solid tu…
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: Clinical Significance of Adherent Perinephric Fat in Patients Undergoing Partial Nephrectomy
A clinical trial update examines the significance of adherent perinephric fat for patients undergoing partial nephrectomy, with the study cu…
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors [Phase 2]
Phase 2 study evaluating APL-101 in non-small cell lung cancer with MET exon 14 skipping mutations and MET dysregulation, as well as other M…
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: ClAmpless, Sutureless PartIAl Nephrectomy for Renal Masses [NA]
An ongoing clinical trial from the University of Florida evaluating a clAmpless, sutureless partial nephrectomy technique for renal cell car…
-
CLINICAL_TRIALS withdrawal · 2025-06-26Clinical Trial Update: iConquerFear Program for the Treatment of Fear of Cancer Recurrence in Patients With Localized Renal Cell Carcinoma
The iConquerFear program for Fear of Cancer Recurrence in patients with localized renal cell carcinoma has been withdrawn from the clinical …
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: Non-Interventional Study (NIS) of Nivolumab With or Without Ipilimumab in Participants With Advanced Kidney Cancer
Non-interventional study evaluating nivolumab with or without ipilimumab in adults with advanced renal cell carcinoma; status is Active Not …
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: Advanced Diffusion Imaging in Renal Cancer Patients [NA]
This clinical trial update notes an ongoing study evaluating advanced diffusion imaging techniques in patients with renal cancer, currently …
-
CLINICAL_TRIALS research · 2025-06-19Clinical Trial Update: Optimization of the Surgical Care Pathway for Kidney Tumors by Digitizing Perioperative Nursing Coordination (UroCCR 126) [NA]
Clinical trial update for optimizing the surgical care pathway for kidney tumors by digitizing perioperative nursing coordination; study cur…
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: Deferred Cytoreductive Nephrectomy in Synchronous Metastatic Renal Cell Carcinoma: The NORDIC-SUN-Trial [NA]
The NORDIC-SUN-Trial is evaluating deferred cytoreductive nephrectomy for patients with synchronous metastatic renal cell carcinoma, and the…
-
CLINICAL_TRIALS trial_result · 2025-06-17Clinical Trial Update: Open vs Robotic Assisted Partial Nephrectomy [NA]
The clinical trial comparing open versus robotic-assisted partial nephrectomy for renal cancer has been terminated.